Insulin glargine (Lantus): Basics, Side Effects & Reviews
Improved Glycemic Control with Insulin Glargine Versus Pioglitazone as Add-On Therapy to Sulfonylurea or Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus - Endocrine Practice
Introduction to Two Recently Approved Insulin Glargine Biosimilars
Toujeo Max SoloSTAR and SoloSTAR Pens | Toujeo® (insulin glargine) injection 300 Units/mL
Update on Basal Insulin Therapy for Type 2 Diabetes Mellitus
Table 2 from Switching from biosimilar (Basalin) to originator (Lantus) insulin glargine is effective in Chinese patients with diabetes mellitus: a retrospective chart review | Semantic Scholar
Important Information Affecting Patients Prescribed LANTUS (Insulin glargine 100 units/mL) - Diabetes And Health Solutions
Lantus Full Prescribing Information, Dosage & Side Effects | MIMS Philippines
Change in glargine dose, dose per weight, and HbA1c. | Download Table
In Brief: Semglee - A New Insulin Glargine for Diabetes | The Medical Letter Inc.